Orange ADR

New guide offers strategies for leveraging nano- and micro-influencers to drive ROI and brand trust in an increasingly crowded digital space AUSTIN, Texas , May 29, 2025 /PRNewswire/ -- Orange 142, a division of Direct Digital Holdings (NASDAQ: DRCT) and a leader in digital marketing for mid-market brands, today released a new best practices guide focused on nano- and micro-influencer marketing, a high-ROI channel that helps brands build trust, engage niche audiences, and drive measurable results. As digital ad saturation continues to rise, marketers turn to micro-influencers, creators with smaller but highly engaged followings, to help build trust, expand reach, and increase conversions.» Mehr auf prnewswire.com

NEWPORT BEACH, CA, May 28, 2025 (GLOBE NEWSWIRE) -- Talonvest Capital, Inc., a boutique commercial real estate advisory firm, participated in the 2025 Walk for Kids, the Orange County Ronald McDonald House's largest annual fundraising event. This year's walk helped raise over $400,000 to provide comfort, care, and support to children and families across Southern California facing pediatric medical challenges.» Mehr auf globenewswire.com

TAMPA, FL, May 19, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to announce that the U.S. Food and Drug Administration (FDA) has listed U.S. Patent Nos. 11890273 (the ‘273 patent) and 12156869 (the '869 patent), each with an expiration date of October 2041, in its Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book) for Arbli™, (losartan potassium) Oral Suspension, 10mg/mL, approved under New Drug Application (NDA# N218772).» Mehr auf globenewswire.com